Seiki, et al, Proc. Natl. Acad. Sci., vol. 80, pp. 3618-3622, 1983. |
Perkins, et al, Science, pp. 421-424, 1984. |
Barany et al., "Solid Phase Peptide Synthesis", in: The Peptides, vol. 2, Academic Press, Inc. pp. 1-284 (1979). |
Cabradilla et al., "Serodiagnosis of Antibodies to the Human AIDS Retrovirus With a Bacterially Synthesized env Polypeptide", Bio/technology, 4:128-133 (1986). |
Chang et al., "Detection of Antibodies to Human T-cell Lymphotropic Virus-III (HTLV-III) With an Immunoassay Employing a Recombinant Escherichia coli-Derived Viral Antigenic Peptide", Bio/technology, 3:905-909 (1985). |
Erickson et al., "Solid Phase Peptide Synthesis", in: The Proteins, 3rd Edition, vol. 2, Academic Press Inc., Chapter 3 pp. 255-527 (1976). |
Gallo et al., "Comparison of Immunofluorescence, Enzyme Immunoassay, and Western Blot (Immunoblot) Methods for Detection of Antibody to Human T-Cell Leukemia Virus Type 1", J. Clin. Micro., 26:1487-1491 (1988). |
Gurtler et al., "Sensitivity and Specificity of Commercial ELISA Kits for Screening Anti-LAV/HTLV III", J. Virol. Met., 15:11-23 (1987). |
Kieny et al., "AIDS VIRUS env Protein Expressed From a Recombinant Vaccinia Virus", Bio/technology, 4:790-795 (1986). |
Lee et al., "High Rate of HTLV-II Infection in Seropositive IV Drug Abusers in New Orleans", Science, 244:471-475 (1989). |
Lerner, "Antibodies of Predetermined Specificity in Biology and Medicine", Advances in Immunol., 36:1-44 (1984). |
Lerner et al., "The Development of Synthetic Vaccines", in: The Biology of Immunologic Disease, Dixon and Fisher eds. Sinaur Associates Inc. MA, pp. 331-338 (1983). |
Marx, "Leukemia Virus Linked to Nerve Disease", Science, 236: 1059-1061 (1987). |
Putney et al., "HTLV-III/LAV-Neutralizing Antibodies to an E. coli-Produced Fragment of the Virus Envelope", Science, 234: 1392-1395 (1986). |
Robert-Guroff et al., "Prevalence of Antibodies to HTLV-1, -II and -III in Intravenous Drug Abusers From an AIDS Endemic Region", J.A.M.A., 255:3133-3137 (1986). |
Rodgers-Johnson et al., "HTLV-I and HTLV-III Antibodies and Tropical Spastic Paraperesis", Lancet, Nov. 30, 1985 pp. 1247-1248. |
Rosenblatt et al., "Integrated Human T-Cell Leukemia Virus II Genome in CD8+ T Cells From a Patient With Atypical Hairy Cell Leukemia: Evidence for Distinct T and B Cell Lymphoproliferative Disorders", Blood, 71:363-369 (1988). |
Rosenblatt et al., "A Second Isolate of HTLV-II Associated with Atypical Hairy-Cell Leukemia", New Engl. J. Med., 315:372-377 (1986). |
Sarngadharan et al., "Human T-cell Leukemia Viruses", Virology, Chapter 58:1345-1371 (1985). |
Shaw et al., "Human T-Cell Leukemia Virus: Its Discovery and Role in Leukemogenesis and Immunosuppression", Year Book Medical Publishers, Inc., pp. 1-27 (1984). |
Shimotohno et al., "Complete Nucelotide Sequence of an Infections Clone of Human T-Cell Leukemia Virus Type II: An open Readinjg Frame for the Protease Gene", Proc. Natl. Acad. Sci. USA, 82:3101-3105 (1985). |
Tedder et al., "Low Prevalance in the UK of HTLV-I and HTLV-II Infection in Subjects with AIDS, With Extended Lymphadenopathy, and at Risk of AIDS", Lancet, Jul. 21, 1984 p. 125-127. |
Vernant et al., "Endemic Tropical Spastic Paraparesis Associated With Human T-Lymphotropic Virus Type I: A Clinical and Seroepidemiological Study of 25 Cases", Ann. Neurol., 21:123-130 (1987). |